
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Intrinsic Value
The intrinsic value of one
TNXP
stock under the Base Case scenario is
77.58
USD.
Compared to the current market price of 28.33 USD,
Tonix Pharmaceuticals Holding Corp
is
Undervalued by 63%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Tonix Pharmaceuticals Holding Corp
Fundamental Analysis


Revenue & Expenses Breakdown
Tonix Pharmaceuticals Holding Corp
Balance Sheet Decomposition
Tonix Pharmaceuticals Holding Corp
Current Assets | 119m |
Cash & Short-Term Investments | 98.8m |
Receivables | 4.8m |
Other Current Assets | 15.4m |
Non-Current Assets | 43.9m |
PP&E | 42.8m |
Intangibles | 120k |
Other Non-Current Assets | 951k |
Free Cash Flow Analysis
Tonix Pharmaceuticals Holding Corp
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Tonix Pharmaceuticals Holding Corp
Revenue
|
10.1m
USD
|
Cost of Revenue
|
-7.8m
USD
|
Gross Profit
|
2.3m
USD
|
Operating Expenses
|
-80.1m
USD
|
Operating Income
|
-77.7m
USD
|
Other Expenses
|
-52.3m
USD
|
Net Income
|
-130m
USD
|
TNXP Profitability Score
Profitability Due Diligence
Tonix Pharmaceuticals Holding Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Score
Tonix Pharmaceuticals Holding Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
TNXP Solvency Score
Solvency Due Diligence
Tonix Pharmaceuticals Holding Corp's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
Tonix Pharmaceuticals Holding Corp's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TNXP Price Targets Summary
Tonix Pharmaceuticals Holding Corp
Dividends
Current shareholder yield for TNXP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TNXP
stock under the Base Case scenario is
77.58
USD.
Compared to the current market price of 28.33 USD,
Tonix Pharmaceuticals Holding Corp
is
Undervalued by 63%.